Home

300px-Teal_ribbon.svg
Ovarian Cancer 
Can genomic profiles predict drug response?

Neuropsychiatric Disease:

Integrating Genomics and Metabolomics

Figure3c.001

GlycerolipidMetaolismPaCa

Pancreatic Cancer:
The role for metabolic reprogramming in drug resistance